These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 27642077)

  • 21. Antidepressant-like activity of selective serotonin reuptake inhibitors combined with a NK1 receptor antagonist in the mouse forced swimming test.
    Chenu F; Guiard BP; Bourin M; Gardier AM
    Behav Brain Res; 2006 Sep; 172(2):256-63. PubMed ID: 16806519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serotonin Synthesis and Reuptake in Social Anxiety Disorder: A Positron Emission Tomography Study.
    Frick A; Åhs F; Engman J; Jonasson M; Alaie I; Björkstrand J; Frans Ö; Faria V; Linnman C; Appel L; Wahlstedt K; Lubberink M; Fredrikson M; Furmark T
    JAMA Psychiatry; 2015 Aug; 72(8):794-802. PubMed ID: 26083190
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vortioxetine versus placebo in major depressive disorder comorbid with social anxiety disorder.
    Liebowitz MR; Careri J; Blatt K; Draine A; Morita J; Moran M; Hanover R
    Depress Anxiety; 2017 Dec; 34(12):1164-1172. PubMed ID: 29166552
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
    Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
    Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of acute tryptophan depletion in serotonin reuptake inhibitor-remitted patients with generalized anxiety disorder.
    Hood SD; Hince DA; Davies SJ; Argyropoulos S; Robinson H; Potokar J; Nutt DJ
    Psychopharmacology (Berl); 2010 Feb; 208(2):223-32. PubMed ID: 19936713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice.
    Guiard BP; Przybylski C; Guilloux JP; Seif I; Froger N; De Felipe C; Hunt SP; Lanfumey L; Gardier AM
    J Neurochem; 2004 Apr; 89(1):54-63. PubMed ID: 15030389
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of citalopram and moclobemide in patients with social phobia: some preliminary findings.
    Atmaca M; Kuloglu M; Tezcan E; Unal A
    Hum Psychopharmacol; 2002 Dec; 17(8):401-5. PubMed ID: 12457375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antidepressants for social anxiety disorder: A systematic review and meta-analysis.
    Mitsui N; Fujii Y; Asakura S; Imai H; Yamada H; Yoshinaga N; Kanai Y; Inoue T; Shimizu E
    Neuropsychopharmacol Rep; 2022 Dec; 42(4):398-409. PubMed ID: 35848723
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A 24-week randomized, double-blind, placebo-controlled study of escitalopram for the prevention of generalized social anxiety disorder.
    Montgomery SA; Nil R; Dürr-Pal N; Loft H; Boulenger JP
    J Clin Psychiatry; 2005 Oct; 66(10):1270-8. PubMed ID: 16259540
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Escitalopram attenuates fear stress-induced increase in amygdalar dopamine following methamphetamine-induced sensitisation: Implications of fine-tuning action of selective serotonin reuptake inhibitors on emotional processing.
    Muraoka H; Oshibuchi H; Kawano M; Kawano T; Tsutsumi T; Yamada M; Ishigooka J; Nishimura K; Inada K
    Eur J Pharmacol; 2018 Sep; 834():1-9. PubMed ID: 29981749
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effects of the co-administration of the α₁-adrenoreceptor antagonist prazosin on the anxiolytic effect of citalopram in conditioned fear stress in the rat.
    Takamura N; Masuda T; Inoue T; Nakagawa S; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Oct; 39(1):107-11. PubMed ID: 22658980
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin synthesis rate and the tryptophan hydroxylase-2: G-703T polymorphism in social anxiety disorder.
    Furmark T; Marteinsdottir I; Frick A; Heurling K; Tillfors M; Appel L; Antoni G; Hartvig P; Fischer H; Långström B; Eriksson E; Fredrikson M
    J Psychopharmacol; 2016 Oct; 30(10):1028-35. PubMed ID: 27189957
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Local infusion of citalopram into the basolateral amygdala decreased conditioned fear of rats through increasing extracellular serotonin levels.
    Kitaichi Y; Inoue T; Nakagawa S; Omiya Y; Song N; An Y; Chen C; Kusumi I; Koyama T
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():216-22. PubMed ID: 24928686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacotherapy for anxiety and comorbid alcohol use disorders.
    Ipser JC; Wilson D; Akindipe TO; Sager C; Stein DJ
    Cochrane Database Syst Rev; 2015 Jan; 1(1):CD007505. PubMed ID: 25601826
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A selective neurokinin-1 receptor antagonist in chronic PTSD: a randomized, double-blind, placebo-controlled, proof-of-concept trial.
    Mathew SJ; Vythilingam M; Murrough JW; Zarate CA; Feder A; Luckenbaugh DA; Kinkead B; Parides MK; Trist DG; Bani MS; Bettica PU; Ratti EM; Charney DS
    Eur Neuropsychopharmacol; 2011 Mar; 21(3):221-9. PubMed ID: 21194898
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.
    Herpfer I; Lieb K
    CNS Drugs; 2005; 19(4):275-93. PubMed ID: 15813642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of the selective serotonin reuptake inhibitor citalopram in the treatment of generalized social phobia.
    Bouwer C; Stein DJ
    J Affect Disord; 1998 Apr; 49(1):79-82. PubMed ID: 9574863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Escitalopram in the treatment of social anxiety disorder: randomised, placebo-controlled, flexible-dosage study.
    Kasper S; Stein DJ; Loft H; Nil R
    Br J Psychiatry; 2005 Mar; 186():222-6. PubMed ID: 15738503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Treatment-resistant anxiety disorders: A literature review of drug therapy strategies].
    Ammar G; Naja WJ; Pelissolo A
    Encephale; 2015 Jun; 41(3):260-5. PubMed ID: 25439852
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tryptophan depletion reverses the therapeutic effect of selective serotonin reuptake inhibitors in social anxiety disorder.
    Argyropoulos SV; Hood SD; Adrover M; Bell CJ; Rich AS; Nash JR; Rich NC; Witchel HJ; Nutt DJ
    Biol Psychiatry; 2004 Oct; 56(7):503-9. PubMed ID: 15450786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.